Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Are you comfortable using low molecular weight heparin as an alternative to unfractionated heparin for ESKD patients on nocturnal home hemodialysis?
Related Questions
What medications do you use to treat encapsulating peritoneal sclerosis?
Would you recommend temporary transition to hemodialysis in a peritoneal dialysis patient who has risk factors, such as recurrent peritonitis, for the development of encapsulating peritoneal sclerosis?
Would you make any dialysis prescription modifications for an ESKD patient who develops tachycardia during a hemodialysis session?
Do you use a profile with high ultrafiltration rates interrupted by UF pauses to manage ESKD patients prone to intradialytic hypotension?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
For optimal GDMT for patients with HFrEF and co-existing ESRD, is there evidence to support the use of SGLT2 inhibitors and/or ARB/ARNI?
Would you use IV albumin before hemodialysis for hypotension if the serum albumin is greater than 3.5 g/dl?
How would you manage an ESKD patient who complains of severe fatigue after hemodialysis, but does not experience intradialytic or post-dialysis hypotension and has not responded to dry weight adjustments?
Which ESKD patients would you consider transitioning from hemodialysis to hemodiafiltration, given the FDA approval of a hemodiafiltration system in the US?
Do you prefer automated peritoneal dialysis during the day or night for a hospitalized patient with ESKD on PD?
